Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Senescence”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05109598
What this trial is testing

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Not applicableStudy completedNCT04788758
What this trial is testing

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Thomas Jefferson University 76
Not applicableLooking for participantsNCT06946654
What this trial is testing

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Who this might be right for
ElderlyGeriatric AssessmentALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital 176
Testing effectiveness (Phase 2)Study completedNCT04640402
What this trial is testing

A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 960
Testing effectiveness (Phase 2)Ended earlyNCT00968331
What this trial is testing

Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
University of Bologna 25
Not applicableStudy completedNCT01956331
What this trial is testing

Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Groupe Francais De Pneumo-Cancerologie 302
Testing effectiveness (Phase 2)Looking for participantsNCT06136351
What this trial is testing

The Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma, Mantle-Cell
Ruijin Hospital 23
Testing effectiveness (Phase 2)Ended earlyNCT04161118
What this trial is testing

TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
University of Cologne 3
Large-scale testing (Phase 3)Study completedNCT01450449
What this trial is testing

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
International Atomic Energy Agency 115
Not applicableStudy completedNCT04450589
What this trial is testing

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss

Who this might be right for
Androgenetic AlopeciaAndrogenic AlopeciaTelogen Effluvium+3 more
Arbor Life Labs 46
Large-scale testing (Phase 3)Study completedNCT03351361
What this trial is testing

Nivolumab and Ipilimumab Versus Chimiotherapy in First Line Treatment in PS 2 or Elderly in Advanced NSCLC Patients

Who this might be right for
Advanced Non Small Cell Lung Cancer
Rennes University Hospital 217
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Testing effectiveness (Phase 2)Study completedNCT00408460
What this trial is testing

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more
University of Washington 34
Post-approval studies (Phase 4)Study completedNCT03022396
What this trial is testing

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010

Who this might be right for
Influenza
Stanford University 82
Testing effectiveness (Phase 2)UnknownNCT02792491
What this trial is testing

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Who this might be right for
Diffuse Large B-cell Lymphoma
Pusan National University Hospital 57
Testing effectiveness (Phase 2)Study completedNCT01553786
What this trial is testing

Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)

Who this might be right for
T-cell Lymphoma
The Lymphoma Academic Research Organisation 80
Not applicableStudy completedNCT02032693
What this trial is testing

Everycell's Effect on DNA Damage, Inflammation, and Stress

Who this might be right for
Family Member
University of Miami 30
Post-approval studies (Phase 4)UnknownNCT04863638
What this trial is testing

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated

Who this might be right for
Covid19
China National Biotec Group Company Limited 4,400
Large-scale testing (Phase 3)Ended earlyNCT00644306
What this trial is testing

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

Who this might be right for
Newly Diagnosed, Multiple Myeloma
Central Hospital, Nancy, France 232
Testing effectiveness (Phase 2)Study completedNCT00283244
What this trial is testing

Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 147
Next Page